Sugi Predict

Sugi Predict / Compounds / SCHEMBL2224713

SCHEMBL2224713

SCHEMBL2224713

CC1(C)CCCc2ccc(-c3csc(N4CCC(NCCO)CC4)n3)cc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.40
▸ PTPN6 P29350 1/20 0.40
▸ CDC25A P30304 1/20 0.40
▸ CTSL P07711 2/20 0.40
▸ CTSB P07858 2/20 0.40
▸ CTSS P25774 2/20 0.40
▸ SMN1; SMN2 Q16637 14/20 0.39
▸ RAB9A P51151 9/20 0.39
▸ NPC1 O15118 7/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ MCOLN3 Q8TDD5 1/20 0.38
▸ KMT2A Q03164 2/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223928 0.95 PTPN1 (0.39) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2223192 0.94 PTPN1 (0.41) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2284199 0.89 PTPN1 (0.40) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2222935 0.89 CTSL (0.37) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2223866 0.89 PTPN1 (0.42) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2225352 0.87 PTPN1 (0.40) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2225816 0.85 SMN1; SMN2 (0.42) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2357757 0.84 CTSL (0.39) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL2226663 0.84 PTPN1 (0.39) PTPN1PTPN6CDC25ACTSLCTSB
SCHEMBL12516993 0.83 RAB9A (0.40) PTPN1PTPN6CDC25ACTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8907098-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8907098-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8907098-B2 Inhibitors of sphingosine kinase MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
EP-2513066-A1 SPHINGOSINE KINASE INHIBITORS Merck Patent GmbH (DE) 2012-10-24 — — EP disclosed
US-20120252815-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 — — US disclosed
US-20120252815-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 — — US disclosed
US-20120252815-A1 INHIBITORS OF SPHINGOSINE KINASE MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-10-04 — — US disclosed
WO-2011082732-A1 SPHINGOSINE KINASE INHIBITORS MERCK PATENT GMBH (DE) 2011-07-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252815-A1 INHIBITORS OF SPHINGOSINE KINASE SPHK1, S1PR3, SPHK2 PTPN1 1189/4885PTPN6 1363/4885CDC25A 816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.